BLI Berkeley Lights

Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022 

Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022 

EMERYVILLE, Calif., April 26, 2022 (GLOBE NEWSWIRE) --  Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the first quarter 2022 after market on Monday, May 9, 2022. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.  

Live audio of the webcast will be available on the “Investors” section of the Company’s website at The webcast will be archived and available for replay after the event. 

About Berkeley Lights 



Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain. 

Forward-Looking Statements 

To the extent that statements contained in this press release are not descriptions of historical facts regarding Berkeley Lights or its products, they are forward-looking statements reflecting the current beliefs and expectations of management. Such forward-looking statements involve substantial known and unknown risks and uncertainties that relate to future events, and actual results and product performance could differ significantly from those expressed or implied by the forward-looking statements. Berkeley Lights undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties relating to the Company’s growth and continual evolution see the statements in the "Risk Factors" sections, and elsewhere, in our filings with the U.S. Securities and Exchange Commission.  

 

Media Contact 

 



Investor Contact 



EN
26/04/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Berkeley Lights

 PRESS RELEASE

Berkeley Lights to Participate at the 27th European Society for Animal...

Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® Platform EMERYVILLE, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 27th Annual European Society for Animal Cell Technology (ESCAT), being held from June 26 - 29, 2022 at the Lisbon Congress Centre in Lisbon, Portugal. This year’s conference, with the motto, “Adv...

 PRESS RELEASE

Berkeley Lights Reports First Quarter 2022 Financial Results

Berkeley Lights Reports First Quarter 2022 Financial Results EMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today reported financial results for the quarter ended March 31, 2022. Recent Highlights Delivered total revenue of $20.2 million for the first quarter of 2022, representing growth of 8.5% year over yearSigned a strategic partnership agreement with Vestaron to develop pesticidal peptides using the Company’s Beacon® platform and proprietary high-throughput, functional screening service Released an upgrade ...

 PRESS RELEASE

Berkeley Lights to Participate in the 18th Annual PEGS Boston Conferen...

Berkeley Lights to Participate in the 18th Annual PEGS Boston Conference & Expo Company’s latest data to be presented on “Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification” EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 18th Annual PEGS Boston Conference, a protein engineering and cell therapy summit, being held virtually and in person from May 2-6, 2022 at the Hynes Convention Center. Berkeley Lights’ participation this year...

 PRESS RELEASE

Berkeley Lights to Report First Quarter 2022 Financial Results on May ...

Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022  EMERYVILLE, Calif., April 26, 2022 (GLOBE NEWSWIRE) --  Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the first quarter 2022 after market on Monday, May 9, 2022. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.   Live audio of the webcast will be available on the “Investors” section of the Company’s website at The webcast will be a...

 PRESS RELEASE

Berkeley Lights Announces Appointment of Lucas S. Vitale as Chief Huma...

Berkeley Lights Announces Appointment of Lucas S. Vitale as Chief Human Resources Officer EMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the appointment of Lucas Vitale to the newly created role of Chief Human Resources Officer (“CHRO”), effective immediately. Vitale will lead Berkeley Lights' Human Resources function. He will report directly to the Company’s Chief Executive Officer (CEO), Dr. Siddhartha Kadia. As Berkeley Lights’ newly appointed CEO, Dr. Kadia is focused on the further development of...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch